Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureNamrata P. Awasthi, Thulasi Raman Ramalingam, Gauri Gaur
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
openalex
Confidence 95%
datacite
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Screening of carcinoma metastasis by flow cytometry: A study of 238 cases
10.1002/cyto.b.21258 · 2016
Usefulness of intraoperative rapid flow cytometry in the surgical treatment of brain tumors
10.1111/neup.12883 · 2023
The role of fast cell cycle analysis in pediatric brain tumors
10.1159/000439029 · 2015
Limit of blank, limit of detection and limit of quantitation
2008
Mass cytometry: Technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry
10.1021/ac901049w · 2009
Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry
10.1002/cyto.b.20525 · 2010
EpCAM signaling promotes tumor progression and protein stability of PD-L1 through the EGFR pathway
10.1158/0008-5472.can-20-1264 · 2020
Advances in intraoperative flow cytometry
10.3390/ijms232113430 · 2022
Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases
10.1309/m877-qabm-d9gb-fjax · 2002
Confidence 0%
Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS - Part i - ale and aims
10.1002/cyto.b.21104 · 2013
Diagnostic accuracy of flow cytometry in detecting malignant epithelial cells in serous effusions
10.1016/j.jasc.2023.09.003 · 2023
Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
10.1007/s10555-020-09898-3 · 2020
Flow cytometry in the detection of circulating tumor cells in neoplastic effusions
10.1016/j.cca.2023.117651 · 2024
Is Ep-CAM expression a diagnostic and prognostic biomarker for colorectal cancer? A systematic meta-analysis
10.1016/j.ebiom.2017.05.025 · 2017
PD-1/PD-L1 pathway: Current researches in cancer
2020
Diagnostic value of D2-40 immunostaining for malignant mesothelioma: A meta-analysis
10.18632/oncotarget.19041 · 2017
Recent advances in the diagnosis and management of malignant pleural effusions
10.1016/s0025-6196(11)60848-3 · 2008
Palliation of malignant ascites
10.1002/jso.25453 · 2019
MUC1 and metastatic cancer: Expression, function and therapeutic targeting
10.4161/cam.23131 · 2013
Flow cytometry as the new ‘gold standard’ for detection of free tumour cells in abdominal lavage fluid in gastric cancer patients: A comparative study of molecular and conventional methods
10.1111/1744-1633.12173 · 2016
Carcinoembryonic antigen expression in human tumors: A tissue microarray study on 13,725 tumors
10.3390/cancers16234052 · 2024
PD-1 and PD-L1 in cancer immunotherapy: Clinical implications and future considerations
10.1080/21645515.2019.1571892 · 2019
A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors
2018
Malignant ascites: Etiology, diagnosis, and treatment
1991
An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions
10.1002/cyto.b.20608 · 2011
Validation of high-sensitivity flow cytometry for reliable immune cell analysis in real-world laboratory settings
10.3343/alm.2023.43.6.620 · 2023
Flow cytometric quantification of intraperitoneal free tumor cells in patients with peritoneal metastasis
10.1002/cytob.21126 · 2014
Unresolved referenced work
2006
Flow immunocytochemistry of marker expression in cells from body cavity fluids
10.1002/cyto.a.20824 · 2010
Deep-coverage single-cell metabolomics enabled by ion mobility-resolved mass cytometry
10.1038/s41592-025-02970-2 · 2026
Standardizing immunophenotyping for the human immunology project
10.1038/nri3158 · 2012
Publication of optimized multicolor immunofluorescence panels
10.1002/cyto.a.20916 · 2010
Intraoperative flow cytometry for the rapid diagnosis and validation of surgical clearance of non-melanoma skin cancer: A prospective clinical feasibility study
10.3390/cancers16040682 · 2024
Intraoperative flow cytometry upon and beyond the cell cycle: A case study of the characterization of a bone metastasis
10.3390/jmp4040020 · 2023
Epithelial cell adhesion molecule (EpCAM) expression in human tumors: A comparison with pan-cytokeratin and TROP2 in 14,832 tumors
10.3390/diagnostics14101044 · 2024
Pre-analytical issues in effusion cytology
10.1515/pp-2016-0001 · 2016
The emerging role of EpCAM in cancer and stem cell signaling
10.1158/0008-5472.can-09-0654 · 2009
Microfluidic devices to enrich and isolate circulating tumor cells
10.1039/c5lc00947b · 2015
The evolution of spectral flow cytometry
10.1002/cyto.a.24566 · 2022
Malignant pleural effusion: A multidisciplinary approach
2024
Rare event detection and analysis in flow cytometry: Bone marrow mesenchymal stem cells, breast cancer stem/progenitor cells in malignant effusions, and pericytes in disaggregated adipose tissue
10.1007/978-1-61737-950-5_12 · doi-reference
Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry
10.1002/cyto.b.21239 · doi-reference
The utility of flow cytometry in the diagnostic workup of malignant effusions due to nonhematopoietic neoplasms
10.1002/cyto.b.21886 · doi-reference
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers
10.1038/sj.bjc.6602924 · doi-reference
Ultra-fast, label-free isolation of circulating tumor cells from blood using spiral microfluidics
10.1038/nprot.2016.003 · doi-reference
SYTO dyes and histoproteins—Myriad of applications
10.1002/cyto.a.20588 · doi-reference
EpCAM expression in primary tumour tissues and metastases: An immunohistochemical analysis
10.1136/jcp.2011.090274 · doi-reference
Role of CD14 in human disease
10.1111/imm.13634 · doi-reference
Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in serosal cavity fluids
10.1002/dc.21047 · doi-reference
Application of multicolour flow cytometry in the detection of metastatic carcinoma in serous effusions: Special emphasis in atypical cytology
10.1111/cyt.12922 · doi-reference
The role of intraoperative flow cytometry in surgical oncology: A systematic review
10.3390/cancers17243898 · doi-reference
Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings
10.1136/jcp.53.7.513 · doi-reference
Simple and rapid flow cytometry assay for the detection of malignant epithelial cells in body fluids
10.1111/cyt.13408 · doi-reference
Role of high acquisition flow cytometry in the detection of marrow involvement in patients with extramedullary B cell non-Hodgkins lymphoma: a comparison with marrow aspirate cytology, trephine biopsy, and PET
10.1080/10428194.2022.2092858 · doi-reference
Intraoperative flow cytometry in detecting free carcinoma cells in peritoneal lavage fluid of gastric carcinoma cases
10.1002/cyto.b.22238 · doi-reference
A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies
10.1309/ajcp4hifshmo9wtk · doi-reference
Epithelial cell adhesion molecule expression (CD326) in cancer: A short review
10.1016/j.ctrv.2011.04.002 · doi-reference